Clinical Topics
-
Is early-onset cancer an emerging global epidemic? -
Cost paramount when choosing metastatic breast cancer treatment -
Genetic tests create treatment opportunities and confusion for breast cancer patients -
Time to cancer diagnoses in U.S. averages 5 months -
Single Institution Retrospective Review of Patterns of Care and Disease Presentation in Female Veterans With Breast Cancer During the COVID-19 Pandemic
Digital Edition
Multimedia
Conference Coverage
-
Multiprong strategy makes clinical trials less White -
CBSM phone app eases anxiety, depression in cancer patients -
T-DXd active in many solid tumors; ‘shift in thinking’ -
Huge underuse of germline testing for cancer patients -
‘Professional grief’ is a daily reality for oncologists -
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncology -
‘New standard of care’ for capecitabine hand-foot syndrome -
Less therapy may suit older patients with breast cancer -
New study backs up capecitabine dosing practice in metastatic BC -
In TNBC, repeated biopsies may reveal emergent HER2-low expression
Question 1 of 5
